Differences in peptide presentation between B27 subtypes: The importance of the P1 side chain in maintaining high affinity peptide binding to B{black star}2703

Immunity

Volumn 1, Issue 2, 1994, Pages 121-130

  Colbert, Robert A ^a   Rowland Jones, Sarah L ^b   McMichael, Andrew J ^b   Frelinger, Jeffrey A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; DNA; HLA B27 ANTIGEN; INFLUENZA A VIRUS NUCLEOPROTEIN; NUCLEOPROTEIN; PEPTIDE;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTHRITIS; ARTICLE; BINDING SITE; CLASSIFICATION; CYTOTOXIC T LYMPHOCYTE; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; SITE DIRECTED MUTAGENESIS; SPINE DISEASE;

ALLELES; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTHRITIS; BASE SEQUENCE; BINDING SITES; DNA; HLA-B27 ANTIGEN; HUMAN; INFLUENZA A VIRUS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEOPROTEINS; PEPTIDES; PROTEIN BINDING; SPINAL DISEASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC; VIRAL CORE PROTEINS;

EID: 0028426881     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/1074-7613(94)90105-8     Document Type: Article

References (70)

1. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis
2. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules
3. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis
4. Guilt by association: HLA-1327 and ankylosing spondylitis
5. Structure of the human class I histocompatibility antigen, HLA-A2
6. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens
7. Structure, function, and diversity of class I major histocompatibility complex molecules
8. Peptide induced changes in class I heavy chains after allorecognition
9. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses
10. Transfer of the inflammatory disease of HLA-1327 transgenic rats by bone marrow engraftment
11. Subtypes of HLA-827 detected by cytotoxoc T lymphocytes and their role in self-recognition
12. Distribution of HLA-827 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules
13. Effect of a Tyr-to-His point-mutation at position 59 in the alpha-1 helix of the HLA-1327 class-I molecule on allospecific and virus-specific cytotoxic T-lymphocyte recognition
14. Ankylosing spondylitis and HL-A27
15. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide
16. Structure and diversity of HLA-1327-specific T cell epitopes: analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism
17. Presentation of viral antigen controlled by a gene in the major histocompatibility complex
18. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules
19. Apparent lack of MHC restriction in binding of class I HLA molecules to solid-phase peptides
20. Changes at peptide residues buried in the major histocompatibility complex (MHC) class I binding cleft influence T cell recognition: a possible role for indirect conformational alterations in the MHC class I or bound peptide in determining T cell recognition
21. Molecular analysis of the variant alloantigen HLA-B27d (HLA-B∗2703) identifies a unique single amino acid substitution
22. A novel HLA-B27 allele maps B27 allospecificity to the region around position 70 in the alpha 1 domain
23. Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus antigenic peptides
24. Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.
25. New genes in the MHC that encode proteins for antigen processing
26. Recognition of HLA B27 and related antigens by a monoclonal antibody
27. A method to quantitate binding of unlabeled peptides to class I MHC molecules and detect their allele specificity
28. Allele-specific motifs revealed by sequencing of selfpeptides eluted from MHC molecules
29. Sequence determinants of cytosolic N-terminal protein processing
30. Evidence of widespread binding of HLA class I molecules to peptides
31. b
32. Specificity pockets for the side chains of peptide antigens in HLA-Aw68
33. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle
34. Spontaneous inflammatory disease in transgenic rats expressing HLA-1327 and human b2-m: an animal model of HLAB27-associated human disorders
35. Different rates of HLA class 1 molecule assembly which are determined by amino acid sequence in the a2 domain
36. HLA class I typing by PCR: HLA-1327 and an African B27 subtype
37. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling
38. Structural homologies between two HLA B27 restricted peptides suggest residues important for interaction with HLA B27
39. Identification of self peptides bound to purified HLA-1327
40. An overview of clinical spectrum and heterogeneity of spondyloarthropathies
41. A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells
42. Peptide-presenting similarities among functionalloy distant HLA-1327 subtypes revealed by alloreactive T lymphocytes of unusual specificity
43. HLA-B27 and HLA-A2 subtypes: structure, evolution and function
44. HLA-1327 subtypes: implications for the spondyloarthropathies
45. The structure of HLA-827 reveals nonamer self peptides bound in an extended conformation
46. The three-dimensional structure of HLA-1327 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC
47. Roles of the six peptide binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones
48. Emerging principles for the recognition of peptide antigens by MHC class I molecules
49. Mutations in the α1 domain of a class I gene define residues important for specific allorecognition
50. An improved biochemical method for the analysis of HLA-class I antigens: definition of new HLA-class I subtypes
51. Use of monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens
52. Sequence motifs important for peptide binding to the human MHC class I molecule HLA-A2
53. Genetic modulation of antigen presentation by HLA-B27 molecules
54. Changes in the repertoire of peptides bound to HLA-1327 subtypes and to site-specific mutants inside and outside pocket B
55. ★2705 peptide motifs
56. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
57. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids
58. Refined structure of the human major histocompatibility antigen HLA-A2 at 2.6 Å resolution
59. High association of an HL-A antigen, W27, with ankylosing spondylitis
60. Atomic structure of a human MHC molecule presenting an influenza virus peptide
61. NK susceptibility varies inversely with target cell class I HLA antigen expression
62. Susceptibility to inflammatory disease in HLA-1327 transgenic rat lines correlates with the level of B27 expression
63. Identification of several functional subgroups of HLA-1327 by restriction of the activity of antiviral T killer lymphocytes
64. Delineation of functional sites in HLAB27 antigens: molecular analysis of HLA-1327 variant Wewak I defined by cytoloytic T lymphocytes
65. Role of binding pockets for amino-terminal peptide residues in HLA-1327 allorecognition
66. Biochemical specificity of H-2M3: stereospecificity and space-filling requirements at position 1 maintain N-formyl peptide binding
67. ★0201: effect on maturation and peptide presentation
68. The HLA-A,B “negative” mutant cell line C1R expresses a novel HLA-1335 allele, which also has a point mutation in the translation initiation codon
69. b molecule containing a single viral peptide: implications for peptide binding and T cell receptor recognition
70. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells